??????????????? (the Role of Molecular Typing in Nosocomial Infection Control) - PowerPoint PPT Presentation

1 / 51
About This Presentation
Title:

??????????????? (the Role of Molecular Typing in Nosocomial Infection Control)

Description:

the Role of Molecular Typing in ... resistance epidemiologic typing PFGE( ... Methods for data collection ... – PowerPoint PPT presentation

Number of Views:365
Avg rating:3.0/5.0
Slides: 52
Provided by: dmar55
Category:

less

Transcript and Presenter's Notes

Title: ??????????????? (the Role of Molecular Typing in Nosocomial Infection Control)


1
???????????????(the Role of Molecular Typing in
Nosocomial Infection Control)
?????????? ??????????? ? ?
2
????(????????)
  • ?????????????????????????,?????????????????,??????
    ????????????????
  • ???????????????????
  • ????????????
  • ???????????????????????????????

?????????????????????????????
3
?????????????
  • accurately identifying nosocomial pathogens
  • detecting unexpected antimicrobial-drug
    resistance
  • epidemiologic typing
  • ??
  • ????????
  • ??????

Pfaller MA et al. The clinical microbiology
laboratory and infection control emerging
pathogens, antimicrobial resistance, and new
technology. Clin Infect Dis 199725858-70.
4
  • ????
  • ????
  • ????????
  • PFGE(???????)
  • RAPD(????DNA???)
  • REA(?????)
  • ribotyping (?????)

5
1????????(PFGE)
???????
? ?
? ?
????
????
6
??????DNA
PFGE??
7
PFGE??
  • ??

Enzyme
  • ?520????10800kb????DNA

8
  • Tenover FC.et al.J Clin Microbiol,199533(9)2233
    2239

9
PFGE??
????
10
??
??????
DNA
???????
11
PFGE??
?????
  • ????
  • ??????????? 2.5 ?
  • ?????????--???
  • ??--???
  • ?????--???

12
(No Transcript)
13
PFGE????
  • ???
  • ????????????(CDC)Tenover??????????
  • ????????????,????????????????????,??2-3???????????
    ,??4-6?????????,????7????????????????????????A?B?C
    ?D?????????
  • ????
  • ?????SPSS,????

14
PFGE?????
15
PFGE??
  • DNA?????,?????
  • ??????????
  • ???????

16
2?RAPD(????DNA???)
  • 1990?
  • WilliamsRAPD
  • WelshAP-PCR
  • ?????
  • ??
  • ? ??? ?????,??910bp
  • ????????
  • ????????,2535?

17
  • ESHWAR MAHENTHIRALINGAM.et al.J Clin
    Microbiol,199634(5)11291135

18
  • ESHWAR MAHENTHIRALINGAM.et al.J Clin
    Microbiol,199634(5)11291135

19
  • ESHWAR MAHENTHIRALINGAM.et al.J Clin
    Microbiol,199634(5)11291135

20
???????????????
21
Special Issue New Technology for Detecting
Multidrug-Resistant Pathogens in the Clinical
Microbiology Laboratory Lance R. Peterson and
Gary A. NoskinNorthwestern Memorial Hospital
and Northwestern University Medical School,
Chicago, Illinois, USA
EID, 2001, 7 306
22
  • Northwestern Memorial Hospital, Chicago
  • 700-bed, university-affiliated medical center
  • ??gt39,000/?
  • ??56,000?/?
  • ???260,000/?

23
??????????
5.79
P0.002
LR Peterson et al, EID, 2001, 7 306
24
??
  • the total number of nosocomial infections per
    1,000 patient days??????????
  • the number of patients with nosocomial infections
    per 100 patient discharges
    ?100???????????
  • (percentage of patients with nosocomial
    infection)
  • (?????????)

25
??????????
  • We formed a permanent, integrated infection
    control and prevention program that fully
    incorporates
  • ????
  • ?????
  • ??
  • ?????
  • infection control personnel,
  • infectious disease personnel,
  • pharmacy personnel,
  • clinical microbiology personnel
  • into a single working group to minimize hospital
    infections.

Hacek DM et al. Am J Clin Pathol 1999111647-54.
26
??????(Methods for data collection)
  • review of microbiology reports
  • review of patients' medical records,
  • direct observation of medical and nursing
    practice,
  • active surveillance of rectal cultures of
    patients in nursing units for high-risk patients,
  • evaluation of suspected nosocomial infections
    reported by health-care providers.
  • ???????
  • ??????
  • ????????????
  • ???????????????
  • ???????????????

????????????????????,??????????,????????????
??????????
27
  • Two interventions
  • a molecular typing laboratory
  • a weekly planning meeting
  • infection control
  • diagnostic medical microbiology (molecular
    epidemiology)
  • Pharmacy
  • and infectious diseases
  • ?????????
  • ????
  • ??
  • ?????????
  • ????
  • ?????(??????)
  • ??
  • ?????

28
  • ????
  • ??????(?????)
  • ??????????????????
  • ????????
  • ??????????????
  • weekly meetings
  • the ongoing short- and long-term trends in
    nosocomial infections within the center
  • activities of the infection control professionals
    and microbiology laboratory personnel
  • any needed changes were determined.
  • The organizational structure for selecting
    microbes for typing was shared by the medical
    directors of infection control and clinical
    microbiology

29
?????????
  • routinely genomically typedVRE
  • Periodic routine typing
  • fluoroquinolone-resistant P. aeruginosa,
  • methicillin-resistant Staphylococcus aureus
    (MRSA),
  • Enterobacter cloacae,
  • Clostridium difficile
  • Additional organisms for typingselected through
    surveillance of microbiology culture reports
    discussed at the weekly meeting.
  • ??????VRE
  • ?????
  • ?????????
  • MRSA
  • ?????
  • ????
  • ????????????????????????????

????????????????,????????????????????????
30
????
  • REA analysis
  • restriction of genomic DNA with conventional
    electrophoresis
  • DNA?????

31
????????
??-????(Analysis of Cost Data)
  • the cost of equipment, remodeling,
  • reagent and other supplies,
  • salaries and benefits for three technologists,
  • plus all the institutional assessments (e.g.,
    full-cost basis) required to operate a hospital
    laboratory.
  • ??????????????
  • ????????
  • ????????
  • ???????(?full-cost basis )????????

????t??
32
??
  • 1?VRE
  • initial impetus serious nosocomial
    problem---VRE's emergence
  • molecular typing results
  • a pattern of numerous mini patient-to-patient
    outbreaks of distinct clones
  • rather than the spread of a single persisting
    strain
  • 1?VRE
  • ????VRE??????
  • ??????
  • ???????(mini)?????
  • ??????????

33
??
  • ???????????????
  • ????????(high conality, gt90)
  • ????(moderate clonality, 35-75)
  • ?????(lt20 clonality).
  • ?????,??????????
  • genomic typing
  • patient-to-patient transmission
  • nosocomial outbreak
  • little evidence of horizontal spread
  • Using this information, we determined what
    intervention was likely to control an apparent
    outbreak (20).

34
high conality, gt90 likely patient-to-patient transmission
moderate clonality, 35-75 possibly nosocomial outbreak
clonality, lt20 unlikely little evidence of horizontal spread
similarity
35
  • ??????,???25????????
  • VRE
  • ?????????
  • MRSA
  • ??
  • ????
  • During the last 2 years of this study,
  • 25 possible microbial outbreaks were
    investigated by the typing laboratory
  • VRE,
  • fluoroquinolone-resistant P. aeruginosa,
  • MRSA,
  • E. cloacae,
  • C. difficile.

36
  • Classic Spread of Nosocomial Infection
  • VRE 19 strains, from 16 patients, in a 2-month
    period
  • 14 strains from one of two clones (88)
  • Indicating a high probability of nosocomial
    spread
  • Review
  • microbiology laboratory culture
    requisitions---no close contact.
  • Patients existing direct connection between
    11/14 patients (14).
  • infection control practices aborted the outbreak
  • ?????????
  • VRE 19?, ??16???,2?????
  • ???????????????? (88)
  • ????????
  • ????
  • ?????? ?????????
  • ??14???11??????
  • ????????

37
Moderate Likelihood of Spread of Nosocomial
Infections
  • ?????NI??
  • 1?????,????
  • ???????
  • ??????
  • ??????
  • ??????
  • 40-60 clonality
  • ??????????????????
  • ??
  • ??????
  • ??????
  • ??????
  • During a 1-month period, in a special-care unit
  • invasive infections, caused by five isolates
  • Klebsiella pneumoniae,
  • S. epidermidis, and
  • S. hemolyticus
  • DNA typing indicated 40 to 60 for each of the
    bacterial species.
  • patients with genetically identical organisms
    occupied adjacent beds.
  • Erecting a barrier on the unit, along with
    educating medical staff, halted the spread of
    these infections (15).

38
Outbreaks not Caused by Patient-to-Patient Spread
  • 2????ICU??
  • 4???,64??????
  • 21 clonality
  • ?????????indicating unlikely patient-to-patient
    spread.
  • ???????????????
  • ??????
  • ??????
  • Suspected outbreaks consisting of four isolates
    of K. pneumonia and 64 strains of Serratia
    marcescens were investigated in the ICUs of two
    hospitals. Both investigations showed 21
    clonality, indicating unlikely patient-to-patient
    spread.
  • Investigation suggested suboptimal handling of
    ventilator equipment, and both outbreaks were
    stopped by retraining of personnel using this
    equipment

39
  • Pseudooutbreaks
  • Possible outbreaks occurred in the special-care
    nursery units of two hospitals, each of which had
    its own molecular typing section.
  • seven S. aureus strains, and the other of four
    isolates of gram-negative bacilli.
  • immediately typed and no (20) clonality existed.
  • No interventions were instituted, and the
    apparent outbreaks were determined to be normal
    variation in infections (15,21).
  • avoided culture-based surveillance investigation
    of staff by the state department of health, and
    the other avoided closing the unit for a 30-day
    full disinfection and cleaning (done in previous
    suspected outbreaks).
  • 2???,??????,???????????????
  • 7???
  • ??????rapid typing
  • no (20) clonality
  • ??????
  • ??
  • ??????????(??)
  • ????30?,?????
  • 4?G-?

40
??????????
P0.000006
LR Peterson et al, EID, 2001, 7 306
41
??????????
5.79
P0.002
LR Peterson et al, EID, 2001, 7 306
42
  • nosocomial infection 3.3-2.6 (national rate
    4.4-5)
  • gt1,400 fewer patients acquired infections during
    this time,
  • averting more than 50 expected deaths
  • Even with endemic VRE, most of our outbreaks
    involve three or fewer patients (19).
  • ????3.3???2.6(???????4.4-5)
  • ??gt1,400?????
  • ?????gt50
  • VRE????????????

43
??
  • The mean number of patients with nosocomial
    infections decreased by 283 per year, a reduction
    of more than 1,100 inpatient days.
  • The costs avoided by using this calculation
    averaged more than 2,150,000/year, based on 1999
    dollars.
  • ?????????????? 283,????????1100?
  • ?????????????2,150,000(?1999???)

44
  • Representatives now meet together for 45 minutes
    each week
  • For Microbiology, opening the typing laboratory
    totaled 180,050. By the fifth year, costs in the
    laboratory section were stable.
  • The cost for the laboratory, includng three
    medical technologists, is 400,000 yearly.
  • Virtually all these costs are borne by the
    hospital.
  • ????????????,45min,??
  • ?????????????(?????)????180,050.
  • ???????????400,000
  • ????

45
  • While such a grant program would cost up to 2
    billion each year if all U.S. hospitals
    participated,
  • the projected reduction in cost of treating
    nosocomial infections could reach over five times
    that amount.
  • a savings of 5.00 for each dollar spent.
  • ????????
  • ????????????20???
  • ?????????????????5?(100?)!
  • ???1????5??

46
  • Typing time within 1 week
  • 48 hours.
  • Lack of clonality suggests other reasons for the
    apparent outbreak,
  • antimicrobial-agent use pressure,
  • failure of appropriate nursing-care practices,
  • or simply random variation in the number of
    infections.
  • Early knowledge of whether microbial clonality is
    present or absent focuses the scope of an
    investigation and facilitates appropriate
    intervention.
  • ??1?,48h
  • ?????????,???????
  • ?????,
  • ??????(?????),
  • ????????????
  • ??????????????????????

47
  • cost of rapid detection using the polymerase
    chain reaction (PCR)
  • one day of glove isolation
  • could be completed in a single 8-hour workday.
  • As gene chip technology moves into clinical use,
    detecting a large number of resistance
    determinants soon after a patient is admitted to
    the hospital should be possible.
  • PCR ??
  • ?????????
  • 8???????????
  • ????
  • ???
  • ????
  • ????????

48
?????????????
  • technically possible
  • medically useful
  • economically justified

49
  • ???????????????
  • ?????????????????
  • ???????????
  • ??-????
  • ????????
  • ??

50
????
  • ???? 04?05?
  • ?????????(PRAB) ?????????
  • ????????(PFGE)??
  • ??????????PRAB?????
  • ???????????????????PRAB???
  • ????,????????
  • ????????????????
  • ?????????????
  • ????????????????????

51
Thank You
Write a Comment
User Comments (0)
About PowerShow.com